# OnCo record paper-varshney-neoadjuvant-incidental-gallbladder-cancer-systematic-review-ahbps-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-varshney-neoadjuvant-incidental-gallbladder-cancer-systematic-review-ahbps-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-varshney-neoadjuvant-incidental-gallbladder-cancer-systematic-review-ahbps-2025" ;
  schema:name "Neoadjuvant treatment for incidental gallbladder cancer: A systematic review"@en ;
  schema:description "A review of whether chemotherapy should come before the second operation for gallbladder cancer found by chance: recurrences after that operation are early and distant, so treating the whole body first makes sense, and the limited evidence favours three to four cycles of gemcitabine-based chemotherapy in higher-risk cases."@en ;
  schema:url <https://onco.cc/key-papers/paper-varshney-neoadjuvant-incidental-gallbladder-cancer-systematic-review-ahbps-2025/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.14701/ahbps.24-223>, <https://pubmed.ncbi.nlm.nih.gov/40064481/> ;
  onco:tag "gallbladder-evidence" ;
  schema:sameAs <https://doi.org/10.14701/ahbps.24-223> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Varshney P, Baghmar S, Sirohi B, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-cisplatin/> ;
  onco:terms <https://onco.cc/cancers/incidental-gallbladder-cancer/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:trials <https://onco.cc/trials/opt-in/>, <https://onco.cc/trials/gain-igbc/> .
